Maternal probiotic milk intake during pregnancy and breastfeeding complications in the Norwegian Mother and Child Cohort Study
- PMID: 31506766
- PMCID: PMC7351866
- DOI: 10.1007/s00394-019-02072-8
Maternal probiotic milk intake during pregnancy and breastfeeding complications in the Norwegian Mother and Child Cohort Study
Abstract
Purpose: During the time of breastfeeding, a third of all women contract (or: fall ill in) mastitis-the leading cause of precocious weaning. Recent studies indicate that probiotics intake may prevent mastitis by altering the breast's bacterial flora. The aim of this study was to examine whether probiotic milk intake during pregnancy is associated with less breastfeeding complications and longer breastfeeding duration.
Methods: This study included 57,134 women, with live singleton term births, participating in the Norwegian Mother and Child Cohort Study. Probiotic milk intake during the first half of pregnancy was self-reported in a validated food frequency questionnaire at gestational week 22. At 6 month postpartum, women reported complications, including mastitis, and duration and exclusivity of breastfeeding. The association between probiotic milk intake and breastfeeding complications and duration was studied by adjusted logistic regression models.
Results: Probiotic milk intake was associated with increased risk for mastitis [adjusted odds ratio (aOR) 1.09, 95% confidence interval (CI) 1.02-1.16] and for any breastfeeding problems during the first month (aOR 1.19, 95% CI 1.10-1.21). However, cessation of predominant (aOR 0.95, 95% CI 0.91-0.96) or any (aOR 0.79, 95% CI 0.75-0.84) breastfeeding earlier than at 4 months was less frequent in probiotic milk consumers than in non-consumers.
Conclusions: Even though probiotic milk intake during the first half of pregnancy was statistically associated with increased risk for breastfeeding complications, including mastitis, the association is probably not causal. Probiotics intake was namely associated with longer breastfeeding duration and there was indication of socioeconomic confounding. Further studies, i.e., large randomized-controlled trials, are needed to understand the association between probiotic intake and breastfeeding complications.
Keywords: Breastfeeding complications; Cessation of breastfeeding; Mastitis; Probiotic milk intake; Probiotics; The Norwegian Mother and Child Cohort Study.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
Timing of probiotic milk consumption during pregnancy and effects on the incidence of preeclampsia and preterm delivery: a prospective observational cohort study in Norway.BMJ Open. 2018 Jan 23;8(1):e018021. doi: 10.1136/bmjopen-2017-018021. BMJ Open. 2018. PMID: 29362253 Free PMC article.
-
Intake of probiotic food and risk of preeclampsia in primiparous women: the Norwegian Mother and Child Cohort Study.Am J Epidemiol. 2011 Oct 1;174(7):807-15. doi: 10.1093/aje/kwr168. Epub 2011 Aug 5. Am J Epidemiol. 2011. PMID: 21821542 Free PMC article.
-
Incidence, antibiotic treatment and outcomes of lactational mastitis: Findings from The Norwegian Mother, Father and Child Cohort Study (MoBa).Paediatr Perinat Epidemiol. 2022 Mar;36(2):254-263. doi: 10.1111/ppe.12824. Epub 2021 Nov 28. Paediatr Perinat Epidemiol. 2022. PMID: 34841537
-
Effectiveness of breast massage for the treatment of women with breastfeeding problems: a systematic review.JBI Database System Rev Implement Rep. 2019 Aug;17(8):1668-1694. doi: 10.11124/JBISRIR-2017-003932. JBI Database System Rev Implement Rep. 2019. PMID: 31135656
-
Probiotics and human lactational mastitis: A scoping review.Women Birth. 2020 Nov;33(6):e483-e491. doi: 10.1016/j.wombi.2020.01.001. Epub 2020 Mar 4. Women Birth. 2020. PMID: 32146088
Cited by
-
The preventive and therapeutic effects of probiotics on mastitis: A systematic review and meta-analysis.PLoS One. 2022 Sep 9;17(9):e0274467. doi: 10.1371/journal.pone.0274467. eCollection 2022. PLoS One. 2022. PMID: 36084006 Free PMC article.
-
Probiotics Supplementation during Pregnancy: Can They Exert Potential Beneficial Effects against Adverse Pregnancy Outcomes beyond Gestational Diabetes Mellitus?Biology (Basel). 2024 Feb 28;13(3):158. doi: 10.3390/biology13030158. Biology (Basel). 2024. PMID: 38534428 Free PMC article.
-
The Role of Targeted Microbiota Therapy in the Prevention and Management of Puerperal Mastitis.Diseases. 2025 Jun 5;13(6):176. doi: 10.3390/diseases13060176. Diseases. 2025. PMID: 40558587 Free PMC article. Review.
References
-
- WHO (2000) Mastitis—causes and management. World Health Organization (WHO), Geneva, Switzerland.
-
- WHO (2001) The optimal duration of exclusive breastfeeding—report of an expert consultation. World Health Organization (WHO), Geneva.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources